chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After a few minutes of administration, I felt tingling down my right arm, my right side of the face, and my tongue. My eye started to hurt with pressure. The tingling in my arm and hand went away after 30 minutes or so but there was still some tingling of my face, toungue and the pressure of the eye still remained. That night I took a Zyrtec and felt better for a few days. on 1/8 I started to feel tinging in my tongue and pressure in my right eye again. I took Zyrtec that night and it went away. Currently this morning I feel okay and hope it wont come back.
The blister is gone but a black spot is still there.; blister on left arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 30Mar2021 (Lot number: EP6955, Expiration Date: Jun2021) at the age of 47 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: VITAMIN C [ASCORBIC ACID]; CALCIUM. Vaccination history included: Bnt162b2 (First dose: given on 09Mar2021. Lot number: EN6199. Expiry: unknown. NDC: unknown. Given in left arm.), administration date: 09Mar2021, when the patient was 47 years old, for COVID-19 immunization. The following information was reported: VACCINATION SITE VESICLES (non-serious) with onset 30Mar2021, outcome "recovered", described as "blister on left arm"; VACCINATION SITE DISCOLOURATION (non-serious), outcome "not recovered", described as "The blister is gone but a black spot is still there.".  Additional Information: Caller stated he took the Pfizer COVID vaccine on 30Mar2021. It was the second dose. He had a blister on left arm. The blister appeared within 1 hour of getting the second dose of the Pfizer COVID vaccine. He got the second dose around 12 PM or 1PM. The blister went away in about 4 or 5 days. Then it became a black spot. The black spot is still there. Today he took the booster shot and they said he needed to call and report it. What does he have to do with the left arm? The black spot is too much. Is there some way for them to send that to his email address? It is looking bad. It has never looked like that. Right now he doesn't know if the booster will do the same. No other vaccines given within 4 weeks except the first dose of the Pfizer COVID vaccine. The patient did not went to emergency room/physician office.  No follow-up attempts are possible. No further information is expected.  Follow-up (30Nov2021): Follow-up attempts are completed. No further information is expected.
No adverse event; Vaccine administered after beyond use date; This spontaneous case was reported by a non-health professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date) and NO ADVERSE EVENT (No adverse event) in an 8-month-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 09-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            No concomitant medication information was reported.  The vaccine was received at the clinic on 07-Jun-2022.  The vaccine beyond use date was reported as 07-Jul-2022.  No treatment information was provided.
chills; headache; body aches; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49 year-old female patient received bnt162b2 (BNT162B2), administration date 18Mar2021 14:00 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Von Willebrand's disease" (unspecified if ongoing); "Drug allergies: Penicillin" (unspecified if ongoing); "Drug allergies: Cephalosporins." (unspecified if ongoing); "Oral contraceptive" (unspecified if ongoing); "supplement" (unspecified if ongoing). Concomitant medication(s) included: PROGESTERONE taken for oral contraception; FIBERCON; VITAMIN D [VITAMIN D NOS] taken for supplementation therapy. Past drug history included: Ibuprofen, reaction(s): "Drug allergies: Ibuprofen"; Acetaminophen, reaction(s): "Drug allergies: Acetaminophen"; Moxifloxacin, reaction(s): "Drug allergies: Moxifloxacin"; Ibuprofen, reaction(s): "Erythema multiform", notes: after having take both of them several years ago (so advised to avoid both).; Acetaminophen, reaction(s): "Erythema multiforme", notes: after having take both of them several years ago (so advised to avoid both). Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 immunisation. The following information was reported: CHILLS (non-serious) with onset Mar2021, outcome "unknown", described as "chills"; HEADACHE (non-serious) with onset Mar2021, outcome "unknown", described as "headache"; PAIN (non-serious) with onset Mar2021, outcome "unknown", described as "body aches".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a physician concerning a female patient who on an unknown date was vaccinated with GARDASIL 0.5 mL IM.  Subsequently, the patient became "lethargic" after getting GARDASIL.  The patient sought unspecified medical attention.  Additional information has been requested.
positive COVID test on 10/10/21; unable to acquire any more records from the hospital at this time; per death certificate pt died in the hospital with the causes of death listed as AHRF, COVID Pneumonia, Acinetobacter Pneumonia, Rheumatoid Arthritis
patient complaining of chills and body aches which started around 12:00pm day after vaccine
Patient tested positive for Covid on 10/05/2021.  Symptoms included sore throat and cough.  No underlying health conditions listed in disease reporting system or charted.  Patient died 10/26/2021
From initial information received on 11Jan05 from a RN regarding an adverse event occurring, it was reported that a five year old male pt received a dose of Daptacel, lot number C1700AA, a dose of Ipol, lot number not reported, and a dose of MMR, lot number not reported, all administered in the right thigh on an unspecified date in Oct of 2004. The routes of admin were not reported. Approx two hrs later, the pt's thigh was burning hot from the top of the thigh to his knee. The pt also developed a 4x8 cm purple area around the site of injection and hives in the 4x8 inch area. In addition, the pt had difficulty walking. He was given Benadryl by his mother. Reportedly, he recovered from these events.
Patient called pharmacy and described red irritation.  She spoke to pharmacist on duty who reassured her it was a possible injection site reaction and should dissipate with time.  On Wednesday 3/4/15, the patient returned to the pharmacy and presented with a red and irregular irritation at the injection site and surrounding areas.  The patient did not complain of pain but the area felt hot to the touch and the patient indicated that the irritation was increasing in size.  I recommended that the patient seek medical attention.  After some hesitation she agreed.  It is unknown if this was an allergic reaction to the vaccine or possible infection post administration.  The physician gave the patient an antibiotic injection and prescriptions for an oral antibiotic along with a corticosteroid.  Patient is to follow up with physician and indicated she would return to pharmacy with any other relevant information.
I developed severe arm pain within 6 hours of getting the vaccine making it difficult to turn to my left side so I could sleep. The following day in less than 24 hours I spiked a 101 fever with chills and fatigue. Took Tylenol and it went away. My arm was still painful with warmth and swelling, noting a red circle approximately 2.5 inches in diameter around the site of injection which was noticed by a friend on 12/26. I continue to have pain in the arm on 12/27 with lessening of warmth and redness but still with swelling.
99 fever, dizzy, nauseous, body aches and pain, headaches, diarrhea. Took Ibuprofen
Mom noted some red bumps on his face on Saturday Then noticed a few more spots Thought maybe it was spider bites Yesterday it really started to get worse. Concerned about had foot and mouth. Has not tried putting anything on the rash, grandma did put calamine Hasn't really noticed him scratching at the spots
Severe chest pains, continuous headache, fever, body aches, and sore throat.
shot was really painful; she could not lift it and today she still has very limited range of motion; Terrible pain in arm, shoulder and back. unable to laterally raise left arm; Terrible pain in arm, shoulder and back. unable to laterally raise left arm; Terrible pain in arm, shoulder and back. unable to laterally raise left arm; This is a spontaneous report from a contactable consumer (patient). A 61-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8730), via an unspecified route of administration, administered in Arm Left on 29Mar2021 08:00 at the age of 61-year-old as dose 2, single for covid-19 immunisation. Medical history included asthma and patient thinks she's allergic to ampicillin and penicillin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and no other medications were received within 2 weeks of vaccination. The patient was not diagnosed with covid prior to vaccination and patient was not tested for COVID-19 post vaccination. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6206), via an unspecified route of administration, administered in arm right on 08mar2021 11:00 at the age of 61-year-old as dose 1, single for covid-19 immunisation and shot she had basically no effects. On 29Mar2021 patient received vaccine in the morning, the shot itself was excruciating, was really painful, she had to wince to get through it. On same day, she had excruciating pain, she could not lift it and today she still has very limited range of motion. She states she took Advil and Tylenol and it is a little bit better on 30Mar2021 but she still can't lift her arm laterally and she is concerned about this. Patient receive injection itself was very high, up to her collarbone, very very high on her arm, she felt like he was forcing the needle through, she could feel it go though whatever tissue it was. Patient had terrible pain in arm, shoulder and back. unable to laterally raise left arm. The outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.
Pt vax; devel sterile abscess at inject site.  Abscess tx w/ packing, sterile dressing, & meds.
All over flu pain morning after shot. Took advil and Tylenol. Extreme irritable and anxious throughout the day. About noon completely exhausted.  Took more advil & Tylenol. Walked the dog. Was dizzy.  Came home. Took a Norco. Went to bed. Woke up 3 hours later with 100 temp and more pain including slight headache. . Took more Advil Tylenol.
Information has been received from a physician assistant concerning unspecified number of patients of unknown demographics. Relevant medical history and drug reactions were not reported. On unknown dates, since the stored temperature excursions which occurred in August 2014, the patients were vaccinated with the improperly stored PNEUMOVAX 23 (dose and route unspecified; lot # K004930 with expiration date: 16-MAR-2015). The physician assistant reported that PNEUMOVAX 23 were all administered prior to their expiration date. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Pfizer COIVD 19 EUA-  Pt was vaccinated @ 0957 7/2/21 at 1 am next  morning pt woke up with widespread itching and rash all over body, feet swelled, fever 103. Pt called the pharmacy was told to call  which was closed Saturday. Pt took Tylenol, ibuprofen & benadryl. Monday she was feeling better so she did not call . Fever broke on 7/6/21 and rash went away on 7/8/21
Sore left arm the day of the vaccination near the site. Throughout the next morning I felt a progressively worsening sore neck, that evolved into a stiff neck by early afternoon. My neck is a bit swollen, on the same side I received the vaccination (Left).
received Menveo lyophilized men-A component after it was reconstituted with a non-GSK inactive diluent; received Menveo lyophilized men-A component after it was reconstituted with a non-GSK inactive diluent; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 12-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA983A, expiry date 30-SEP-2024) for prophylaxis.   On 28-SEP-2023, the patient received Menveo. On 28-SEP-2023, an unknown time after receiving Menveo, the patient experienced wrong solution used in drug reconstitution (Verbatim: received Menveo lyophilized men-A component after it was reconstituted with a non-GSK inactive diluent) and inappropriate dose of vaccine administered (Verbatim: received Menveo lyophilized men-A component after it was reconstituted with a non-GSK inactive diluent).The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 04-OCT-2023 The reporter stated that a patient received Menveo lyophilized men-A component after it was reconstituted with a non-GSK inactive diluent, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow up via email.
Patient presented for second dose of COVID vaccine.  Pfizer vaccine administered to patient before staff realized patient had received first dose of Moderna 21 days prior.  Patient had no adverse side effects.  Was notified and instructed by provider to notify/return or medical if develops any side effects.  Patient verbalized understanding.
Lymphadenopathy - painful swelling in the L axillary lymph node that started 5 days after the 1st dose and lasted for a little longer than 24 hours. There was extending tingling in the L breast area which also started and stopped with the lymph node swelling.
Swelling of breast lymph nodes after first shot; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date Sep2021 (Batch/Lot number: unknown) at the age of 54 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Past drug history included: Codeine, reaction(s): "known allergies: codeine". The following information was reported: LYMPHADENOPATHY (non-serious) with onset Sep2021, outcome "recovered" (2021), described as "Swelling of breast lymph nodes after first shot". The event "swelling of breast lymph nodes after first shot" was evaluated at the physician office visit. Therapeutic measures were not taken as a result of lymphadenopathy.  Additional information: facility where the most recent COVID-19 vaccine was administered was withheld. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient not tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Breakthrough case admission after 3 vaccines Pfizer 5/27/21 Lot# EW0187;  Pfizer 6/17/21 Lot# Ew0196;  Pfizer 12/28/21 Lot# 330258D
Received her first Pfizer COVID vaccine today around 11:25am. She was very reserved and quiet and seemed nervous but pleasant during the vaccine. Immediately after administering the vaccine, I asked her how she was doing, and she claimed to be fine. She left the consultation room. I went to administer a vaccine to the next patient in line. While I was doing the next vaccine, apparently the patient was attempting to walk to a chair and started to tip over (around 11:27am), on the verge of passing out. Her mother and sisters were there to catch her. She claimed her vision was blurry. When I came out of the consultation room, my other RPh, was on the phone with 911 per the mother's request. I went out to check on the patient. She claimed to be dizzy and have blurry vision. She was sipping on water and taking deep breaths. I asked if she was having any trouble breathing, and she denied that. Her face was very pale, and her lips were purplish/bluish. My technician brought out a cool cloth for her mother to put on the back of her neck. I asked her a few more times over the next 5-10 minutes if she was having any trouble breathing, and she denied it every time. When the EMTs arrived, they checked the patient's blood pressure sitting and standing and determined that her reaction/low blood pressure was most likely temporary, related to the vaccine and/or her anxiety about the vaccine. Havilah was not transported to the hospital, and her mother opted to take her home as she was feeling much better about 20 minutes after the initial reaction started.
RED RAISED AREA ABOUT THE SIZE OF A QUARTER ON RIGHT UPPER THIGH.
Chills, shakes, cold, hot, cough, headaches, hard to breathe, all over body pain (not so much the left arm).
Patient reported severe arm pain and that husband had to help her get dressed. Nurse at place of work told her shot was too high on arm. At time of reporting, patient said pain was improving.
Day after shot was intense muscle pains/chills/hot and cold flashes abs dizziness. Took vitamins b,c,d and slept for 5hours and felt so much better. Then on Friday the 24th around 7am peed in bed for the fiirst time since 2years old (didn?t have water/alcohol etc) haven?t done so Again (today is 4/27)
Blood glucose is significantly higher and is very resistant even to insulin injections. Normal fasting runs 120 in the morning. Currently running  155-200 fasting 10 days post vaccine booster.  After insulin it will come down to 120 but if any food or drink is consumed it spikes significantly higher than expected.  Also, typically blood sugars respond to 20% more insulin after a spike from, for example, a high carb meal. After any meal currently the sugars spike and 100% increase requires 2-3 hours to bring blood sugars to 120. I have doubled my insulin dose and my blood sugar remains out of control 10 days post injection. PRIOR TO ANY COVID 19 VACCINATION I WAS WELL CONTROLLED BY SIMPLY TAKING ORAL MEDICATION. AFTER VACCINE I SM OUT OF CONTROL DIABETIC ON OVER 70U of insulin per day . 45 units of Soliqua. Worse after each dose of vaccine. I did see it getting better in the months following vaccine 2. Prior to vaccine 3 I was using 38 units per day.
Pt began having SOB and lethargy around 03/2021.  Increasing SOB in April until May.  6/11/2021 patient had emergent SOB and decreased LOC.  Wife called EMS. Pt transported to ED for eval. Bilateral PE shown on CTA.
Swelling, redness, pain upper arm (our office receiving increased of similar complaints following DTaP over past week).
mom reported pt mouth turning blue last PM & this AM;cried 11/2 hr p/vax then 830PM 23APR96 lips turned blue while lying on stomach;went away slowly when picked up;lips, jaw, hands blue this AM-denied lethargy, LOC, inc temp;
my injected arms' lymph is swollen; fatigue; fever; This is a spontaneous report from a contactable consumer. This consumer (patient) reported for self that,  A 47-years-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot Number: EW0187) (at the age of 47 years old), dose 2 via an unspecified route of administration, administered in arm left on 03Jun2021 09:00 as dose 2, single for covid-19 immunisation in hospital. Historical vaccine, the patient took first dose bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: EW0170), dose 1 via an unspecified route of administration, administered in arm left on 13May2021 09:00 as dose 1, single for covid-19 immunisation. Medical history included blood cholesterol increased from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. It was reported that six hours after he took the second dose, on 05Jun2021 08:00 he started feeling fatigue and fever. In last 48 hours and then, after that he realized that his injected arm lymph was swollen. This was the first time he noticed the reaction after getting any kind of vaccines or injection. No treatment for events was received. Patient did not have covid prior to vaccination. He was not tested for covid post vaccination. The outcome for the events was not recovered.  Follow-Up (04Aug2021): Follow-up attempts are completed. No further information is expected.
received both doses of Shingrix in 2020, but observed and is treating a current shingles outbreak for this patient./Suspected vaccination failure; received both doses of Shingrix in 2020, but observed and is treating a current shingles outbreak for this patient.; This serious case was reported by a physician via sales rep and described the occurrence of vaccination failure in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix and Shingrix, the patient experienced vaccination failure (Verbatim: received both doses of Shingrix in 2020, but observed and is treating a current shingles outbreak for this patient./Suspected vaccination failure) (serious criteria medically significant) and shingles (Verbatim: received both doses of Shingrix in 2020, but observed and is treating a current shingles outbreak for this patient.). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingrix and Shingrix.   Additional Information: Receipt date 7 August 2023: The physician reported that reported he/she saw a patient this morning in her 80's that received both doses of Shingrix in 2020, but observed and was treating a current shingles outbreak for this patient.  This case was considered as suspected vaccination failure since the details regarding time to onset, laboratory confirmation of shingles was not reported.